This Nature review article explores the evolving understanding of type 2 immunity, traditionally associated with defense against parasitic infections and tissue repair. The authors, Marek Wagner, Hiroyoshi Nishikawa, and Shigeo Koyasu, challenge the conventional view that type 2 immunity exclusively promotes tumor growth. Instead, they highlight emerging evidence suggesting its potential role in suppressing or protecting against cancer. The review also examines how these new insights could lead to innovative cancer immunotherapies, emphasizing the nuanced and complex interplay between the immune system and cancer progression.
References:
- Wagner, M., Nishikawa, H. & Koyasu, S. Reinventing type 2 immunity in cancer. Nature 637, 296–303 (2025). doi.org
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
